Otu esi agụ nyocha methylene blue: nduzi ụdị ọmụmụ

Tụlee nsonaazụ abụọ e bipụtara. N'otu, otu dose methylene blue e nyere n'ọnụ mụbara ọrụ ụbụrụ n'oge ọrụ nlebara anya na ncheta ma kwalite iweghachite ncheta site na 7 percent. N'ọzọ, methylene blue belatara ọbara na-eru n'ụbụrụ na metabolism oxygen nke ụbụrụ n'ime ndị ọrụ afọ ofufo ahụike. Otu molecule ahụ, ntụziaka abụọ megidere ibe ha. Onye na-agụ ya nke na-ewere ha abụọ dịka mkpebi ikpe n'otu ajụjụ ga-ekwubi na otu n'ime ha aghaghị ịdị njọ.

Ọ dịghị nke dị njọ. Ha jụrụ ajụjụ dị iche iche, n'ime sistemụ dị iche iche, na dose dị iche iche, site n'ụzọ dị iche iche, tụọ endpoints dị iche iche n'oge dị iche iche. Isiokwu a na-akụziri gị ịhụ ọdịiche ndị ahụ dịka onye nyocha si ahụ ha, ka e wee nwee ike ịhazi nkwupụta ọzọ ị ga-ahụ tupu e kwenye na ya. A kọwara ihe molecule ahụ na-eme n'ọkwa kemịkal n'ime nkọwa mechanism, a kọwakwara ajụjụ banyere otú dose si akpụzi mmetụta n'ime nyocha ihe akaebe dosing. N'ebe a, isiokwu bụ ihe akaebe ahụ n'onwe ya.

Akwụkwọ nyocha ọ bụla na-aza ajụjụ dị warara

Nsonaazụ ọmụmụ abụghị mgbe ọ bụla nkwupụta gbasara methylene blue n'ozuzu ya. Ọ bụ nkwupụta gbasara methylene blue n'ime otu model kpọmkwem, e nyere site n'otu ụzọ kpọmkwem, na otu dose kpọmkwem, tụnyere otu control kpọmkwem, jiri otu endpoint kpọmkwem tụọ ya, n'otu oge kpọmkwem. Gbanwee otu n'ime ihe ndị ahụ, azịza ahụ nwekwara ike ịgbanwe. Oghere asaa, nke ị ga-ejupụta maka akwụkwọ nyocha ọ bụla ị na-agụ:

Model. Sel dị n'efere nyocha, òké, anụ ahụ mmadụ e debere ndụ n'èzí ahụ, ma ọ bụ mmadụ. Nzọụkwụ ọ bụla na-aga elu na-agbakwunye ịdị nso na ezi ọnọdụ ma na-ebelata njikwa.
Ụzọ e si enye ya. Ilo ya, ịgbanye ya n'ime akwara, ịgbanye ya n'ime nkwonkwo, ma ọ bụ iji pipette tinye ya n'elu sel. Ụzọ e si enye ya na-ekpebi ole ga-erute anụ ahụ na ọsọ ọ ga-erute ya.
Nkeji dose. Milligrams kwa kilogram maka anụmanụ na mmadụ, micromolar maka sel na mmiri a na-etinye anụ ahụ. A pụghị iji mgbakọ naanị tụgharịa nkeji ndị a n'etiti ibe ha, n'ihi na absorption, distribution, protein binding, na clearance dị n'etiti ha.
Ihe ntụnyere. Placebo, vehicle solution, anụmanụ a naghị agwọ, ma ọ bụ baseline tupu dose. Nsonaazụ na-enweghị ihe ntụnyere bụ ihe a hụrụ, ọ bụghị nchọpụta.
Endpoints. Ihe a tụrụ n'ezie: mgbaàmà scan ụbụrụ, ọkwa enzyme, njupụta ọkpụkpụ, akara ule. Surrogate markers (ihe ndị na-anọchi anya outcome) abụghị outcome ahụ.
Oge. Otu dose a tụrụ mgbe one hour gachara bụ nkwupụta dị iche na inye dose kwa ụbọchị ruo one year.
Ejighị n'aka. Ọnụọgụ sample, ndị ọrụ afọ ofufo ahụike ma e jiri ha tụnyere ndị ọrịa, na ma ndị ode akwụkwọ n'onwe ha kpọpụtara oke ọmụmụ ahụ. Obere pilot studies na-emepụta hypotheses; ha anaghị edozi ha kpamkpam.

Ihe atụ anọ dị n'okpuru na-ejupụta akwụkwọ ọrụ a maka ezigbo akwụkwọ nyocha, gụnyere abụọ yiri ka ha na-emegide ibe ha.

Ihe atụ 1: nnwale ndị ọrụ afọ ofufo nke hụrụ ọrụ ụbụrụ ka ukwuu

N'ime nnwale imaging randomized, double blind, placebo controlled, ndị okenye ahụike 26 dị afọ 22 ruo 62 mere ọrụ nlebara anya na-adịgide adịgide na ncheta obere oge n'ime scanner, wee loe ma 280 mg methylene blue nke ogo pharmaceutical (ihe dịka 4 mg/kg) ma ọ bụ blue food dye placebo, ma megharịa ọrụ ndị ahụ one hour ka e mesịrị. Otu dye gosipụtara nzaghachi siri ike karịa n'ime insular cortex n'oge nlebara anya na n'ofe netwọkụ prefrontal, parietal, na occipital n'oge ncheta, tinyere 7 percent azịza ziri ezi karịa n'oge retrieval. Nnwale carbon dioxide egosighị mgbanwe na vascular reactivity, nke ndị ode akwụkwọ kọwara dịka ihe akaebe na mgbaàmà ahụ gosipụtara iji oxygen eme ihe kama mmetụta arịa ọbara.

Ịgụ akwụkwọ ọrụ: model, ndị ahụike. Ụzọ e si enye ya, oral capsule. Dose, otu 4 mg/kg. Ihe ntụnyere, placebo nwere blinding nke e chebere site n'ịgwa ndị sonyere ka ha ghara ịmị mamịrị n'etiti session (mamịrị na-acha anụnụ anụnụ ga-eme ka a mata ihe e nyere ha). Endpoints, mgbaàmà scan tinyere akara ọrụ. Oge, one hour mgbe otu dose gasịrị. Ejighị n'aka, mmadụ 26, ahụike, otu session, imaging surrogate kama clinical outcome.

Ihe nke a na-egosi nwere oke ma bụrụkwa ihe e tụrụ n'ezie: otu low oral dose gbanwere ọrụ ụbụrụ metụtara task n'ime ndị okenye ahụike n'ụbọchị ahụ. Ọ naghị anwale ọgwụgwọ ọnọdụ ọ bụla, iji ya ogologo oge, ma ọ bụ dose ọ bụla ọzọ. E kwesịrị ịtụle nkwupụta gbasara ncheta na arụmọrụ ọgụgụ isi n'iburu oke ahụ n'uche.

Ihe atụ 2: esemokwu nke na-abụghị esemokwu n'ezie

Otu ìgwè ọzọ mechara tụọ ọbara na-eru na metabolism ozugbo mgbe e nyere methylene blue n'ime akwara, n'ime ndị ọrụ afọ ofufo ahụike asatọ (0.5 and 1 mg/kg) na n'ime oke (2 and 4 mg/kg). Species abụọ ahụ gosipụtara mbelata global cerebral blood flow; metabolism oxygen mmadụ dara, iji glucose nke oke dara. Nkọwa ndị ode akwụkwọ n'onwe ha bụ omume dose: methylene blue bụ biphasic, na-akpali akpali mgbe exposure dị ala ma na-egbochi mgbe exposure dị elu, ebe a na-akọwakarị low range dịka ihe dị gburugburu 0.5 to 4 mg/kg na reversal n'elu ihe dịka 7 to 10 mg/kg, dabere na model.

Tinye akwụkwọ ọrụ abụọ ahụ n'akụkụ ibe ha, esemokwu ahụ agwụ. Ụzọ dị iche (intravenous ma e jiri ya tụnyere oral), dose dị iche, endpoints dị iche (metabolic rate ma e jiri ya tụnyere task evoked activity), oge dị iche (infusion 30 minutes tupu scanning ma e jiri ya tụnyere capsule one hour tupu ya). Intravenous dose nke rutere ozugbo n'otu oge abụghị exposure yiri nke capsule a na-amịkọrọ site n'afọ na eriri afọ, resting metabolic rate abụghịkwa otu measurement dịka activity n'oge ọrụ ncheta. Akwụkwọ nyocha ndị yiri ka ha na-emegide ibe ha na-abụkarị naanị akwụkwọ na-aza ajụjụ dị iche iche, a kọwakwara dose response story nke na-ejikọta ha n'ime nchịkọta hormesis na dosing.

Ihe atụ 3: anụ ahụ mmadụ a mụrụ n'èzí ahụ

Otu pilot study tinyere sample abụba e wepụtara n'oge ịwa obi n'ime methylene blue. Sample ndị ahụ sitere n'aka ndị ọrịa heart failure 25: epicardial na perivascular adipose tissue, ya bụ abụba gbara obi na arịa ọbara gburugburu nke na-enye aka na oxidative stress. Mgbe e debere ya 24 hours na 0.1 micromolar methylene blue, anụ ahụ gosipụtara expression dị ala nke monoamine oxidase enzymes (ọtụtụ n'ime ya MAO-A) na reactive oxygen species pere mpe. Ịgbakwunye serotonin, MAO-A substrate, mụbara oxidative stress ọzọ, methylene blue wee belata akụkụ nke mmụba ahụ.

Nke a bụ anụ ahụ mmadụ na ezigbo biological effect, mana ọ bụghị treatment trial n'ime mmadụ. E nyeghị onye ọ bụla dose. Enweghị circulation, enweghị metabolism site na liver, enweghị clinical outcome, concentration dị n'efere ahụkwa n'onwe ya anaghị ekwu ihe ọ bụla gbasara oral dose ga-emepụtaghachi ya. Ọrụ ex vivo (anụ ahụ a na-amụ n'èzí ahụ dị ndụ) dị n'etiti cell culture na clinical research: ọ na-egosi na effect nwere ike ime n'ime ihe sitere n'ahụ mmadụ n'okpuru controlled conditions, mana ọ pụghị ịkwado efficacy, safety, ma ọ bụ dosing. Mgbe ị na-agụ akụkọ gbasara tissue findings, lelee ma headline ahụ na-akọwa ihe mere n'efere ahụ ma ọ bụ na-amali ozugbo n'ihe ga-eme n'ime onye ọrịa. A kọwara broader context maka ụdị redox finding a n'ime oxidative stress evidence review.

Ihe atụ 4: ọmụmụ òké ebe nsonaazụ sel na-adịgideghị

Otu mouse aging study nwalere methylene blue ogologo oge megide age related bone loss. Òké nwanyị merela agadi ṅụrụ mmiri nwere 250 micromolar methylene blue ruo 6 or 12 months, a gwọkwara genetically diverse mice site n'oge adulthood ruo old age. N'ime cell culture, compound ahụ belatara osteoclast differentiation, ụdị nsonaazụ na-ebute headlines. N'ime anụmanụ dị ndụ, ọ gbanweghị ihe ọ bụla: cortical na trabecular bone morphology mere agadi kpọmkwem dịka nke òké a naghị agwọ, parallel MitoQ arm dara n'otu ụzọ ahụ.

Nke a bụ translation gap n'ụdị ya kacha doo anya. Efere nyocha na-edobe concentration ka ọ ghara ịgbanwe, na-ewepụ organ system niile, ma na-atụ otu cell behavior. Anụmanụ na-agbakwunye gut, liver, kidneys, hormones, na months of compensation. Null result dịka nke a abụghị ọdịda science; ọ bụ science na-arụ ọrụ, na-ewepụ hypothesis (antioxidant treatment naanị ya na-echebe aging bone) tupu onye ọ bụla emee ya ọzọ n'ime mmadụ. Animal findings na-akwado ma ọ bụ na-eme ka mechanism daa mbà. Ha anaghị akọwa human use, oke dị mkpa mgbe ọ bụla longevity na aging claims na-ezo aka na mouse data.

Akwụkwọ ọrụ ahụ, dị njikere idetuo

Maka akwụkwọ nyocha ma ọ bụ akụkọ gbasara akwụkwọ nyocha ọzọ, dejupụta nke a tupu i kpebie ihe i chere:

Model: sel, animal (species nke ọ bụ, healthy ma ọ bụ diseased), ex vivo human tissue, healthy volunteers, ma ọ bụ patients?
Ụzọ e si enye ya: oral, intravenous, local injection, ma ọ bụ tinye ya ozugbo n'elu sel ma ọ bụ anụ ahụ?
Nkeji dose: mg/kg (body) ma ọ bụ micromolar (dish)? Ejila molecular weight naanị tụgharịa otu gaa na nke ọzọ.
Ihe ntụnyere: placebo, vehicle, untreated group, ma ọ bụ pre dose baseline? E chebere blinding?
Endpoints: a tụrụ ya ozugbo ma ọ bụ surrogate? Mgbaàmà scan, ọkwa enzyme, na disease outcome bụ ike nkwupụta atọ dị iche iche.
Oge: single dose ma ọ bụ chronic? A tụrụ ya mgbe minutes, hours, ma ọ bụ months gachara?
Ejighị n'aka: ole subjects ka e nwere, gịnịkwa ka ndị ode akwụkwọ n'onwe ha kwuru na ọ nwere oke? Pilot, healthy volunteer, na single dose studies na-emepụta hypotheses.

Omume abụọ na-eme ka akwụkwọ ọrụ a bụrụ ngwa ngwa. Nke mbụ, gụọ methods tupu conclusion; conclusion na-agwa gị ihe ndị ode akwụkwọ kwenyere, methods na-agwa gị ihe ha nwere ihe akaebe zuru ezu ikwere. Nke abụọ, mgbe ọmụmụ abụọ ekwekọghị, tụnyere worksheets tupu ịtụnyere verdicts. Ọdịiche dị na model, route, dose, na endpoint na-akọwa ọtụtụ ihe yiri contradictions n'enweghị mkpa ikwu na onye ọ bụla dị njọ.